These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1940256)

  • 1. Prevention of recurrent variceal bleeding in alcoholic cirrhotic patients: prospective controlled trial of propranolol and sclerotherapy.
    Rossi V; Calès P; Burtin P; Charneau J; Person B; Pujol P; Valentin S; D'Aubigny N; Joubaud F; Boyer J
    J Hepatol; 1991 May; 12(3):283-9. PubMed ID: 1940256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of recurrent bleeding in cirrhotics with recent variceal hemorrhage: prospective, randomized comparison of propranolol and sclerotherapy.
    Fleig WE; Stange EF; Hunecke R; Schönborn W; Hurler U; Rainer K; Gaus W; Ditschuneit H
    Hepatology; 1987; 7(2):355-61. PubMed ID: 3549507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variceal recurrence, rebleeding, and survival after endoscopic injection sclerotherapy in 287 alcoholic cirrhotic patients with bleeding esophageal varices.
    Krige JE; Kotze UK; Bornman PC; Shaw JM; Klipin M
    Ann Surg; 2006 Nov; 244(5):764-70. PubMed ID: 17060770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of recurrent esophageal bleeding and survival in patients with alcoholic cirrhosis: a randomized study.
    Urbistondo M; Torres EA; Castro F; Oharriz J; Medina R; Molina A; Marquez E; Rubio CE
    P R Health Sci J; 1996 Sep; 15(3):195-9. PubMed ID: 8994285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention of recurrent hemorrhage in patients with cirrhosis. Results of a controlled trial of propranolol versus endoscopic sclerotherapy].
    Martin T; Taupignon A; Lavignolle A; Perrin D; Le Bodic L
    Gastroenterol Clin Biol; 1991; 15(11):833-7. PubMed ID: 1769473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propranolol in the prevention of recurrent variceal hemorrhage in cirrhotic patients. A controlled trial.
    Garden OJ; Mills PR; Birnie GG; Murray GD; Carter DC
    Gastroenterology; 1990 Jan; 98(1):185-90. PubMed ID: 2403428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of propranolol with injection sclerotherapy in prevention of rebleeding from oesophageal varices in cirrhotic patients.
    Westaby D; Polson R; Gimson A; Hayes P; Williams R
    Drugs; 1989; 37 Suppl 2():42-6; discussion 47. PubMed ID: 2806133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sclerotherapy of esophageal varices using ethanol in combination with propranolol: clinical study of 30 patients].
    Poynard T; Aubert A; Naveau S; Lemman M; Chaput JC
    Gastroenterol Clin Biol; 1988 Dec; 12(12):899-905. PubMed ID: 3069544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propranolol versus sclerotherapy in preventing variceal rebleeding: a randomized controlled trial.
    Terés J; Bosch J; Bordas JM; Garcia Pagán JC; Feu F; Cirera I; Rodés J
    Gastroenterology; 1993 Nov; 105(5):1508-14. PubMed ID: 8224655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventive therapy of first gastrointestinal bleeding in patients with cirrhosis: results of a controlled trial comparing propranolol, endoscopic sclerotherapy and placebo.
    Andreani T; Poupon RE; Balkau BJ; Trinchet JC; Grange JD; Peigney N; Beaugrand M; Poupon R
    Hepatology; 1990 Dec; 12(6):1413-9. PubMed ID: 2258157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does elective sclerotherapy improve the efficacy of long-term propranolol for prevention of recurrent bleeding in patients with severe cirrhosis? A prospective multicenter, randomized trial.
    Ink O; Martin T; Poynard T; Reville M; Anciaux ML; Lenoir C; Marill JL; Labadie H; Masliah C; Perrin D
    Hepatology; 1992 Oct; 16(4):912-9. PubMed ID: 1398497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of a randomized trial comparing distal spleno-renal shunt with endoscopic sclerotherapy in the prevention of variceal rebleeding: a lesson from the past.
    Santambrogio R; Opocher E; Costa M; Bruno S; Ceretti AP; Spina GP
    World J Gastroenterol; 2006 Oct; 12(39):6331-8. PubMed ID: 17072957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of rebleeding from oesophageal varices: two-year follow up of a prospective controlled trial of propranolol in addition to sclerotherapy.
    Vickers C; Rhodes J; Chesner I; Hillenbrand P; Dawson J; Cockel R; Adams D; O'Connor H; Dykes P; Bradby H
    J Hepatol; 1994 Jul; 21(1):81-7. PubMed ID: 7963426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled trial of oral propranolol compared with injection sclerotherapy for the long-term management of variceal bleeding.
    Westaby D; Polson RJ; Gimson AE; Hayes PC; Hayllar K; Williams R
    Hepatology; 1990 Mar; 11(3):353-9. PubMed ID: 2179096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propranolol or endoscopic sclerotherapy in the prevention of recurrence of variceal bleeding. A prospective, randomized controlled trial.
    Alexandrino PT; Alves MM; Pinto Correia J
    J Hepatol; 1988 Oct; 7(2):175-85. PubMed ID: 3057063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propranolol in the prevention of recurrent upper gastrointestinal bleeding in patients with cirrhosis undergoing endoscopic sclerotherapy. A randomized controlled trial.
    Avgerinos A; Rekoumis G; Klonis C; Papadimitriou N; Gouma P; Pournaras S; Raptis S
    J Hepatol; 1993 Sep; 19(2):301-11. PubMed ID: 8301065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prospective controlled study of elective sclerotherapy plus oral propranolol for prevention of recurrent bleeding in cirrhotics with recent variceal hemorrhage].
    Kanazawa H; Watari A; Matsusaka S; Tada N; Miyata K; Saitoh H; Yoshizawa M; Kuroda H; Kobayashi M
    Nihon Shokakibyo Gakkai Zasshi; 1991 Jun; 88(6):1341-8. PubMed ID: 1890760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does propranolol maintain post-sclerotherapy variceal obliteration? A prospective randomized study.
    Lo GH; Lai KH; Lee SD; Tsai YT; Lo KJ
    J Gastroenterol Hepatol; 1993; 8(4):358-62. PubMed ID: 8374092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propranolol alone may not be acceptable to prevent first esophageal variceal bleeding in Japanese cirrhotic patients: randomized controlled trial.
    Tomikawa M; Shimabukuro R; Okita K; Tsutsumi N; Akahoshi T; Hashizume M; Sugimachi K
    J Gastroenterol Hepatol; 2004 May; 19(5):576-81. PubMed ID: 15086603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of propranolol for prevention of recurrent bleeding from esophageal varices between sclerotherapy sessions.
    Lundell L; Leth R; Lind T; Lönroth H; Sjövall M; Olbe L
    Acta Chir Scand; 1990 Oct; 156(10):711-5. PubMed ID: 2264429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.